Philip Wayne Kantoff founded Convergent Therapeutics, Inc.

He is Chief Executive Officer at this company. Dr. Kantoff is also on the board of Context Therapeutics LLC and Context Therapeutics, Inc. and Medicine Professor at Harvard University, Chairman-Medicine Department at Memorial Sloan-Kettering Cancer Center, Chairman-Global Treatment Science Network at Prostate Cancer Foundation and Professor Emeritus-Medicine at Harvard Medical School.

In the past Dr. Kantoff held the position of Principal at National Institutes of Health and Director-Lake Center for Genitourinary Oncology at Dana-Farber Cancer Institute, Inc.

He received a graduate degree from Brown University.